• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Boston 角膜型 1 号后青光眼临床前小鼠模型的展望。

Perspectives for preclinical mouse models of glaucoma after Boston keratoprosthesis type 1.

机构信息

Department of Ophthalmology, Centre hospitalier de l'Université de Montréal (CHUM), 1051 Sanguinet, D.01.2273, Montreal, Quebec, H2X 3E4, Canada; Department of Experimental Surgery, Faculty of Medicine, McGill University, 3655 Promenade Sir William Osler, Montreal, Quebec, H3G 0B1, Canada.

Department of Ophthalmology, Centre hospitalier de l'Université de Montréal (CHUM), 1051 Sanguinet, D.01.2273, Montreal, Quebec, H2X 3E4, Canada.

出版信息

Exp Eye Res. 2021 Jul;208:108615. doi: 10.1016/j.exer.2021.108615. Epub 2021 May 7.

DOI:10.1016/j.exer.2021.108615
PMID:33971222
Abstract

Animal models of the Boston keratoprosthesis type 1 (KPro) are needed to study glaucoma damage after KPro implantation to control for confounding comorbidities common in human KPro recipients. The purpose of this study was to determine the feasibility of establishing a reproducible mouse model of glaucoma after KPro surgery, specifically that of a miniaturized mouse model of KPro (mKPro). In the present study, a total of 20 corneas of donor C57BL/6 mice (n = 10) were implanted in one eye of each recipient BALB/C mouse (n = 20), assembled as part of the mKPro, either with or without intraoperative lensectomy. Main feasibility outcomes consisted in incidence rates of loss of tone, capsule nicking, and lens extrusion, as well as acquisition of posterior segment optical coherence tomography (OCT) images. With lensectomy (n = 10), loss of ocular tone and retinal detachment occurred in 100% of mice. Without lensectomy (n = 10), capsule nicking and opening, as well as lens extrusion, occurred in 80% of mice. Causes of these complications included the large proportion of intraocular volume occupied by the lens, the shallow anterior chamber, and thus the lack of available intraocular volume to implant the KPro if the lens remains present. Successful mouse KPro surgery may require a great deal of practice to be useful as a reproducible model. Animal KPro models ought to be pursued further by research teams in future studies.

摘要

需要建立波士顿角膜假体 1 型(KPro)的动物模型,以研究 KPro 植入后青光眼损伤,以控制人类 KPro 接受者常见的混杂合并症。本研究的目的是确定在 KPro 手术后建立青光眼可重复小鼠模型的可行性,特别是微型小鼠 KPro(mKPro)模型。在本研究中,总共 20 个供体 C57BL/6 小鼠(n=10)的角膜被植入到每个受体 BALB/C 小鼠(n=20)的一只眼睛中,作为 mKPro 的一部分组装,术中是否进行晶状体切除术。主要可行性结果包括眼压丧失、囊袋划痕和晶状体挤出的发生率,以及获得后节光学相干断层扫描(OCT)图像的情况。在进行晶状体切除术(n=10)的情况下,100%的小鼠出现眼压丧失和视网膜脱离。在未进行晶状体切除术(n=10)的情况下,80%的小鼠出现囊袋划痕和裂开,以及晶状体挤出。这些并发症的原因包括晶状体占据的眼内容积比例大、前房浅,因此如果晶状体仍然存在,植入 KPro 可利用的眼内容积有限。成功的小鼠 KPro 手术可能需要大量实践才能成为可重复的模型。动物 KPro 模型应该在未来的研究中由研究团队进一步探索。

相似文献

1
Perspectives for preclinical mouse models of glaucoma after Boston keratoprosthesis type 1.Boston 角膜型 1 号后青光眼临床前小鼠模型的展望。
Exp Eye Res. 2021 Jul;208:108615. doi: 10.1016/j.exer.2021.108615. Epub 2021 May 7.
2
Angle Anatomy and Glaucoma in Patients With Boston Keratoprosthesis.Boston 角膜假体植入患者的角度解剖与青光眼。
Cornea. 2020 Jun;39(6):713-719. doi: 10.1097/ICO.0000000000002216.
3
Artifacts in OCT Retinal Nerve Fiber Layer Imaging in Patients with Boston Keratoprosthesis Type 1.Boston Keratoprosthesis 1 型患者光学相干断层扫描视网膜神经纤维层成像中的伪影。
Ophthalmol Glaucoma. 2024 Mar-Apr;7(2):206-215. doi: 10.1016/j.ogla.2023.09.004. Epub 2023 Oct 1.
4
Glaucoma associated with Boston type I keratoprosthesis.与 Boston Ⅰ型角膜移植术相关的青光眼。
Cornea. 2012 Feb;31(2):134-9. doi: 10.1097/ICO.0b013e31820f7a32.
5
Glaucoma Risk Factors and Outcomes Following Boston Keratoprosthesis Type 1 Surgery.Boston 角膜移植术 1 型手术后青光眼的危险因素和结果。
Am J Ophthalmol. 2021 Jun;226:56-67. doi: 10.1016/j.ajo.2021.01.006. Epub 2021 Jan 22.
6
Blood Levels of Tumor Necrosis Factor Alpha and Its Type 2 Receptor Are Elevated in Patients with Boston Type I Keratoprosthesis.Boston Type I 角膜假体患者的肿瘤坏死因子-α及其 II 型受体的血液水平升高。
Curr Eye Res. 2019 Jun;44(6):599-606. doi: 10.1080/02713683.2019.1568500. Epub 2019 Feb 4.
7
Assessment of the Role and Timing of Glaucoma Surgery in Boston Keratoprosthesis Type 1 Patients.评估青光眼手术在波士顿角膜型 1 号患者中的作用和时机。
Am J Ophthalmol. 2022 Mar;235:249-257. doi: 10.1016/j.ajo.2021.09.005. Epub 2021 Sep 17.
8
Glaucoma Management in Patients With Aniridia and Boston Type 1 Keratoprosthesis.无虹膜症合并波士顿 1 型角膜假体患者的青光眼管理。
Am J Ophthalmol. 2019 Nov;207:258-267. doi: 10.1016/j.ajo.2019.06.018. Epub 2019 Jun 24.
9
Assessment of Glaucomatous Damage After Boston Keratoprosthesis Implantation Based on Digital Planimetric Quantification of Visual Fields and Optic Nerve Head Imaging.基于视野数字平面测量和视神经乳头成像评估波士顿人工角膜植入术后的青光眼性损害
Cornea. 2018 May;37(5):602-608. doi: 10.1097/ICO.0000000000001544.
10
Anterior segment optical coherence tomography in the long-term follow-up and detection of glaucoma in Boston type I keratoprosthesis.眼前节光学相干断层扫描在波士顿 I 型角膜移植术后长期随访和青光眼检测中的应用。
Ophthalmology. 2015 Feb;122(2):317-25. doi: 10.1016/j.ophtha.2014.08.007. Epub 2014 Sep 26.

引用本文的文献

1
The treatment of end-stage corneal disease: penetrating keratoplasty compared with Boston type 1 keratoprosthesis.终末期角膜疾病的治疗:穿透性角膜移植术与波士顿 1 型角膜假体的比较。
Graefes Arch Clin Exp Ophthalmol. 2022 Sep;260(9):2781-2790. doi: 10.1007/s00417-022-05646-1. Epub 2022 Apr 6.